Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612000585820
Ethics application status
Not yet submitted
Date submitted
29/05/2012
Date registered
30/05/2012
Date last updated
30/05/2012
Type of registration
Prospectively registered

Titles & IDs
Public title
Treatment of irritable bowel syndrome: Using dietary carbohydrate restriction and hypnotherapy as complementary therapies
Scientific title
Treatment of irritable bowel syndrome: Using dietary carbohydrate restriction and hypnotherapy as complementary therapies
Secondary ID [1] 280573 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Irritable bowel syndrome 286575 0
Condition category
Condition code
Oral and Gastrointestinal 286852 286852 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Participants are randomised to receive one of three treatment conditions:
1. Hypnotherapy
Hypnotherapy sessions are one hour in duration and will occur weekly for a total of six weeks. Hypnotherapy sessions will be delivered by a registered clinical hypnotherapist, Ms Simone Peters who has specific training and knowledge in using hypnotherapy for the treatment of IBS. Each participant will receive the same information in each of the hypnotherapy sessions. Participants will also be required to listen to a daily hypnosis audiotape. This audiotape will be a recording of the first hypnosis session.

2. Low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides and polyols) dietary intervention
The low FODMAP dietary intervention will consist of a one hour initial dietary consultation in week one and a review consultation in week six. The low FODMAP diet will be taught by a practicing dietitian, Dr Sue Shepherd who has specific training and knowledge in using the low FODMAP diet for the treatment of IBS. Each participant will receive the same information in the initial and follow up dietary consultations.

3. Combination of both hypnotherapy and low FODMAP diet
The combination treatment condition will include one hour, weekly hypnotherapy sessions for six weeks; one hour initial dietary consultation in week one and review consultation in week six. The hypnotherapy and low FODMAP interventions will be given simultaneously.


Each participant receives the same information in each of the hypnotherapy sessions becuase the sessions are scripted. Therefore, once the participant has entered a state of hypnosis they are essentially read the same 'script' as every other participant in the hypnotherapy condition.

Participants in the low FODMAP treatment condition will be provided with information about the low FODMAP diet i.e. what the low FODMAP diet is, what foods are 'safe' on the low FODMAP diet etc
Participants are then required to utilise the diet themselves. The dietitan, Dr Sue Shepherd will have weekly telephone contact with participants to ensure compliance.
Intervention code [1] 284962 0
Treatment: Other
Intervention code [2] 284971 0
Lifestyle
Comparator / control treatment
Participants are randomised to one of three treatment conditions: hypnotherapy, low FODMAP diet and combination (both hypnotherapy and low FODMAP diet). Before participants are randomised to one of these three treatments they are asked to complete an irritable bowel syndrome gastrointestinal symptom questionnaire which records the amount and severity of gastrointestinal symptoms they are currently experiencing. They are also asked to complete various psychological measures (Hospital Anxiety and Depression Scale - HADS, State-Trait Personality Inventory - STPI, Irritable bowel syndrome - Quality of Life - IBS-QOL). Once these measures have been completed they will be randomised to one of the treatments.

Participants are then asked to complete these same questionnaires at the completion of the treatment condition (either the hypnotherapy, low FODMAP or combined treatment - depending on which treatment they were randomised to).

Therefore, while there is not a control condition as such (i.e. placebo) each participant acts as their own control in that responses to questionnaires following treatment are considered in relation to responses to questionnaires before the commencement of treatment.
Control group
Active

Outcomes
Primary outcome [1] 287206 0
The change in overall gastrointestinal symptom scores (as measured using a 10cm visual analogue scale) on completion of each of the treatment conditions
Timepoint [1] 287206 0
At completion of each treatment condition (2 weeks) and then at 3 and 6 months follow-up
Secondary outcome [1] 297630 0
Assessment of psychological status in pateints on completion of each of the treatment conditions. Psychological status is measued using validaded psychological questionnaires including; HADS, STPI, IBS-QOL (see previous page for questionnaire full names)
Timepoint [1] 297630 0
At completion of each treatmet condition (2 weeks) and then at 3 and 6 months follow-up

Eligibility
Key inclusion criteria
18 years old, met Rome III criteria for IBS, coealic disease excluded by normal duodenal biopsy or HLA DQ2 (human leukocyte antigen) and HLA DQ8 (human leukocyte antigen) negative
Minimum age
18 Years
Maximum age
75 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Marsh 1 or 2 lesions, other significant gastrointestinal disease (e.g. cirrhosis, inflammatory bowel disease), other clinically significant co-morbidity, psychiatric disease, pregnancy, alcoholism

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Particicipants who meet eligibility criteria will be enrolled in the study. Eligible participants will be randomised to one of three treatment conditions:
1. Hypnotherapy
2. Low FODMAP diet
3. Combination (Hypnotherapy & Low FODMAP diet)
Allocation concealment will be performed - participants will be assigned to one of the three treatment conditions by a centrally randomised computer generated list.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Allocation concealment will be performed - participants will be assigned to one of the three treatment conditions by a centrally randomised computer generated list.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/07/2012
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
78
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 285336 0
University
Name [1] 285336 0
Monash University
Country [1] 285336 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Department of Gastroenterology
Block B, Level 6
The Alfred Centre
99 Commercial Road
Prahran VIC 3181
Country
Australia
Secondary sponsor category [1] 284188 0
None
Name [1] 284188 0
Address [1] 284188 0
Country [1] 284188 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 287347 0
The Alfred Research and Ethics Unit
Ethics committee address [1] 287347 0
Ethics committee country [1] 287347 0
Australia
Date submitted for ethics approval [1] 287347 0
01/05/2012
Approval date [1] 287347 0
Ethics approval number [1] 287347 0
1/12/0197

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34238 0
Address 34238 0
Country 34238 0
Phone 34238 0
Fax 34238 0
Email 34238 0
Contact person for public queries
Name 17485 0
Ms Simone Peters
Address 17485 0
Department of Gastroenterology
Block B, Level 6
The Alfred Centre
99 Commercial Road
Prahran VIC 3181
Country 17485 0
Australia
Phone 17485 0
+61 3 9903 0262
Fax 17485 0
+61 3 9903 0556
Email 17485 0
[email protected]
Contact person for scientific queries
Name 8413 0
Ms Simone Peters
Address 8413 0
Department of Gastroenterology
Block B, Level 6
The Alfred Centre
99 Commercial Road
Prahran VIC 3181
Country 8413 0
Australia
Phone 8413 0
+61 3 9903 0262
Fax 8413 0
+61 3 9903 0556
Email 8413 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.